Humana Inc
NYSE:HUM
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
233.89
470.1
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Humana Inc
Wall Street
Price Targets
HUM Price Targets Summary
Humana Inc
According to Wall Street analysts, the average 1-year price target for
HUM
is 291.36 USD
with a low forecast of 250.48 USD and a high forecast of 384.47 USD.
HUM Last Price Targets
Humana Inc
The latest public price target was made on Oct 22, 2024 by
George Hill
from
Deutsche Bank
,
who expects
HUM
stock to
drop by 2%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
George Hill
Deutsche Bank
|
250
USD
Downside 2% |
2 months ago
Oct 22, 2024
|
Deutsche Bank Reiterates Hold Rating on Humana (HUM)
StreetInsider
|
Andrew Mok
Barclays
|
250
USD
Downside 2% |
2 months ago
Oct 10, 2024
|
Humana price target lowered to $250 from $364 at Barclays
TheFly
|
Ben Hendrix
RBC Capital
|
265
USD
Upside 4% |
2 months ago
Oct 8, 2024
|
Humana price target lowered to $265 from $400 at RBC Capital
TheFly
|
David Windley
Jefferies
|
253
USD
Downside 1% |
2 months ago
Oct 7, 2024
|
Humana downgraded to Hold from Buy at Jefferies
TheFly
|
Jessica Tassan
Piper Sandler
|
274
USD
Upside 7% |
2 months ago
Oct 3, 2024
|
Piper downgrades Humana on 'large miscalculation' of star stability
TheFly
|
Kevin Fischbeck
Bank of America Securities
|
247
USD
Downside 3% |
2 months ago
Oct 2, 2024
|
Humana downgraded to Underperform from Neutral at BofA
TheFly
|
|
David Windley
Jefferies
|
419
USD
Upside 64% |
2 months ago
Sep 27, 2024
|
Jefferies Reiterates Buy Rating on Humana (HUM)
StreetInsider
|
|
Frank Morgan
RBC Capital
|
400
USD
Upside 56% |
3 months ago
Sep 5, 2024
|
Humana (HUM) PT Raised to $400 at RBC Capital
StreetInsider
|
Michael Wiederhorn
Oppenheimer
|
400
USD
Upside 56% |
4 months ago
Aug 1, 2024
|
Humana price target raised to $400 from $370 at Oppenheimer
TheFly
|
David MacDonald
Truist Financial
|
400
USD
Upside 56% |
5 months ago
Jul 15, 2024
|
Humana price target raised to $400 from $355 at Truist
TheFly
|
|
Jessica Tassan
Piper Sandler
|
392
USD
Upside 53% |
5 months ago
Jun 25, 2024
|
Humana initiated with an Overweight at Piper Sandler
TheFly
|
|
Andrew Mok
Barclays
|
370
USD
Upside 45% |
6 months ago
Jun 20, 2024
|
Humana price target raised to $370 from $326 at Barclays
TheFly
|
|
Michael Wiederhorn
Oppenheimer
|
370
USD
Upside 45% |
7 months ago
Apr 25, 2024
|
Humana price target lowered to $370 from $415 at Oppenheimer
TheFly
|
|
Frank Morgan
RBC Capital
|
353
USD
Upside 38% |
7 months ago
Apr 25, 2024
|
Humana (HUM) PT Lowered to $353 at RBC Capital
StreetInsider
|
|
Sarah James
Cantor Fitzgerald
|
360
USD
Upside 41% |
7 months ago
Apr 25, 2024
|
Humana (HUM) PT Lowered to $360 at Cantor Fitzgerald
StreetInsider
|
|
Andrew Mok
Barclays
|
310
USD
Upside 21% |
8 months ago
Apr 2, 2024
|
Humana price target lowered to $310 from $356 at Barclays
TheFly
|
|
Unknown Analyst
Truist Financial
|
560
USD
Upside 119% |
1 year ago
Feb 7, 2023
|
Truist Securities Maintains Hold on Humana, Lowers Price Target to $560
Benzinga
|
Unknown Analyst
Cowen & Co.
|
581
USD
Upside 127% |
1 year ago
Feb 6, 2023
|
Cowen & Co. Maintains Outperform on Humana, Lowers Price Target to $581
Benzinga
|
Unknown Analyst
Credit Suisse
|
575
USD
Upside 125% |
1 year ago
Feb 6, 2023
|
Credit Suisse Maintains Outperform on Humana, Lowers Price Target to $575
Benzinga
|
Unknown Analyst
UBS
|
620
USD
Upside 142% |
1 year ago
Feb 2, 2023
|
UBS Maintains Buy on Humana, Lowers Price Target to $620
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HUM's stock price target?
Price Target
291.36
USD
According to Wall Street analysts, the average 1-year price target for
HUM
is 291.36 USD
with a low forecast of 250.48 USD and a high forecast of 384.47 USD.
What is Humana Inc's Revenue forecast?
Projected CAGR
4%
For the last 8 years the
compound annual growth rate for
Humana Inc's revenue is
9%.
The projected
CAGR
for the next 4 years is
4%.
What is Humana Inc's Net Income forecast?
Projected CAGR
5%
For the last 8 years the
compound annual growth rate for
Humana Inc's net income is
9%.
The projected
CAGR
for the next 4 years is
5%.
You don't have any saved screeners yet
